It is a chemicals private limited company based in Raisen, Madhya Pradesh, India, established in 2021.
2021 | Raisen, Madhya Pradesh, India | ActiveScynor Pharmaceuticals Private Limited, a active private limited company, was established on 12 February 2021 in Raisen, Madhya Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239MP2021PTC054905. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.
Its leadership includes Deepak Kumar Tiwari (Director), Phul Kumari Tiwari (Director), Savita Tiwari (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 215, Sheetal Mega City, Phase 2, Dahod Road, Mandideep, Raisen, Madhya Pradesh, 462046.
U24239MP2021PTC054905
054905
12 February 2021
₹1.50 M
₹0.10 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Scynor Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Kumar Tiwari | Director | 12 Feb 2021 | Current |
| Phul Kumari Tiwari | Director | 12 Feb 2021 | Current |
| Savita Tiwari | Director | 12 Feb 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Scynor Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Scynor Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Scynor Pharmaceuticals has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Scynor Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scynor Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Scynor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Scynor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was completed.
Progress on Deepak Kumar Tiwari was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was documented.
The activity Phul Kumari Tiwari was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was completed.
The activity Savita Tiwari was appointed as a Director was appointed as a Director on 12 Feb 2021 & has been associated with this company since 4 years 10 months . was completed.
Scynor Pharmaceuticals Private Limited was registered on 12 Feb 2021 with Roc Gwalior & aged 4 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Scynor Pharmaceuticals Private Limited is U24239MP2021PTC054905.
Scynor Pharmaceuticals Private Limited is headquartered at 215, Sheetal Mega City, Phase 2, Dahod Road, Mandideep, Raisen, Madhya Pradesh, 462046.
Scynor Pharmaceuticals Private Limited was incorporated on 12 February 2021.
The current directors of Scynor Pharmaceuticals Private Limited are
The primary industry of Scynor Pharmaceuticals Private Limited is Chemicals.
Scynor Pharmaceuticals Private Limited is unlisted.
The authorized capital of Scynor Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX